Updated : Thu, November 16, 2023 @ 3:00 PM
Originally published : Mon, June 18, 2012 @ 3:01 PM
Updated : Mon, September 19, 2022 @ 2:07 PM
Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that the company has launched catalogued assays for Stellaris™ RNA FISH. These assays fall into three groups – well characterized RNA targets (“foundation genes”) suitable for use as positive controls, oncogenes, and key mRNAs in the hypusine pathway.
To read the entire story, here's the full press release.
Leave a comment